| Primary information |
|---|
| ID | 13171 |
| Uniprot ID | P10673 |
| Description | Neurotensin/neuromedin N [Cleaved into- Large neuromedin N (NmN-125); Neuromedin N (NN) (NmN); Neurotensin (NT); NT-tail; Tail peptide] |
| Organism | Canis lupus familiaris |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Carnivora; Caniformia; Canidae (dog; coyote; wolf; fox); Canis; Canis lupus (Gray wolf); Canis lupus familiaris (Dog) (Canis familiaris) |
| Subcellular Location | Secreted Cytoplasmic vesicle; secretory vesicle. Note=Packaged within secretory vesicles. |
| Developmental Stage | NA |
| Similarity | Belongs to the neurotensin family. |
| Tissue Specificity | NA |
| Post Translational Modification | NA |
| Function | Neurotensin may play an endocrine or paracrine role in the regulation of fat metabolism. It causes contraction of smooth muscle. |
| Length | 170 |
| Molecular Weight | 19 |
| Name | Neurotensin/neuromedin N |
| Sequence | QLYENKPRRPYILKRGSYYY |
| Sequence map | 480 |
| PDB ID | 3472221; 2341398; 1883359; 1494486 |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|